Scott Giberson
CIK: 0001937585
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SABS
SAB Biotherapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Giberson Scott
Giberson Scott (SEC CIK 0001937585) files insider reports with the SEC as Director of SAB Biotherapeutics, Inc. (SABS).
Signal8 holds 1 ownership filing by Giberson Scott, a Form 4, filed on Dec 18, 2025. Those filings report 1 transaction, the latest on Dec 16, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Giberson Scott's filings is in MIAMI BEACH, FL.
Recent filings by Giberson Scott
- Dec 16, 2025: Grant or award of SABS derivative securities (Form 4, code A).
Other insiders filing for SAB Biotherapeutics, Inc. (SABS)
- Kropotova Alexandra, CHIEF MEDICAL OFFICER
- Sullivan Eddie Joe, PRESIDENT
- Reich Samuel J, CEO
- Bausch Christoph Lawrence, CHIEF OPERATING OFFICER
- To Lucy
- Jain Rita, Director